270 related articles for article (PubMed ID: 16781195)
21. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
Condorelli F; Gnemmi I; Vallario A; Genazzani AA; Canonico PL
Br J Pharmacol; 2008 Feb; 153(4):657-68. PubMed ID: 18059320
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase inhibitors: from chromatin remodeling to experimental cancer therapeutics.
Arts J; de Schepper S; Van Emelen K
Curr Med Chem; 2003 Nov; 10(22):2343-50. PubMed ID: 14529477
[TBL] [Abstract][Full Text] [Related]
23. Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor.
Gimsing P
Expert Opin Investig Drugs; 2009 Apr; 18(4):501-8. PubMed ID: 19335278
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitors--turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases.
Riester D; Hildmann C; Schwienhorst A
Appl Microbiol Biotechnol; 2007 Jun; 75(3):499-514. PubMed ID: 17377788
[TBL] [Abstract][Full Text] [Related]
25. [Assay for inhibitory activity of histone deacetylase].
Yoshida M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.
Shankar S; Srivastava RK
Adv Exp Med Biol; 2008; 615():261-98. PubMed ID: 18437899
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase inhibitors in cancer therapy.
Fouladi M
Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962
[No Abstract] [Full Text] [Related]
28. Targeted histone deacetylase inhibition for cancer therapy.
Vigushin DM; Coombes RC
Curr Cancer Drug Targets; 2004 Mar; 4(2):205-18. PubMed ID: 15032670
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents.
Kim DH; Kim M; Kwon HJ
J Biochem Mol Biol; 2003 Jan; 36(1):110-9. PubMed ID: 12542981
[TBL] [Abstract][Full Text] [Related]
30. Recent progress in the development of assays suited for histone deacetylase inhibitor screening.
Wegener D; Hildmann C; Schwienhorst A
Mol Genet Metab; 2003; 80(1-2):138-47. PubMed ID: 14567963
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors in cancer therapy.
Rasheed WK; Johnstone RW; Prince HM
Expert Opin Investig Drugs; 2007 May; 16(5):659-78. PubMed ID: 17461739
[TBL] [Abstract][Full Text] [Related]
32. HDAC inhibitors: a potential new category of anti-tumor agents.
Pan LN; Lu J; Huang B
Cell Mol Immunol; 2007 Oct; 4(5):337-43. PubMed ID: 17976313
[TBL] [Abstract][Full Text] [Related]
33. The potential of histone deacetylase inhibitors in lung cancer.
Aparicio A
Clin Lung Cancer; 2006 Mar; 7(5):309-12. PubMed ID: 16640801
[TBL] [Abstract][Full Text] [Related]
34. A work in progress: the clinical development of histone deacetylase inhibitors.
Marsoni S; Damia G; Camboni G
Epigenetics; 2008; 3(3):164-71. PubMed ID: 18487953
[TBL] [Abstract][Full Text] [Related]
35. Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update.
Sultana F; Manasa KL; Shaik SP; Bonam SR; Kamal A
Curr Med Chem; 2019; 26(40):7212-7280. PubMed ID: 29852860
[TBL] [Abstract][Full Text] [Related]
36. [[Inhibitors of histone deacetylase as new agents for prevention and treatment of cancer] ].
Jung M
Pharm Unserer Zeit; 2000 Nov; 29(6):385-8. PubMed ID: 11199916
[No Abstract] [Full Text] [Related]
37. Histone deacetylase inhibitors and cancer therapy.
La Thangue NB
J Chemother; 2004 Nov; 16 Suppl 4():64-7. PubMed ID: 15688613
[TBL] [Abstract][Full Text] [Related]
38. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibitors, anticancerous mechanism and therapy for gastrointestinal cancers.
Fang JY
J Gastroenterol Hepatol; 2005 Jul; 20(7):988-94. PubMed ID: 15955204
[TBL] [Abstract][Full Text] [Related]
40. Targeting histone deacetylase in cancer therapy.
Lin HY; Chen CS; Lin SP; Weng JR; Chen CS
Med Res Rev; 2006 Jul; 26(4):397-413. PubMed ID: 16450343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
